VMAT Radiotherapy Margins for Head and Neck Sarcoma
For VMAT radiotherapy of head and neck sarcoma, use a planning target volume (PTV) margin of 3-5 mm from the clinical target volume (CTV), with the specific margin determined by your daily image guidance capabilities and tumor location.
Evidence-Based Margin Recommendations
Standard PTV Margins with Daily Image Guidance
The available evidence, while not specific to head and neck sarcomas, provides strong guidance from head and neck cancer radiotherapy that can be applied to this rare tumor type:
With daily cone-beam CT (CBCT) guidance: A 3 mm CTV-to-PTV margin is safe and effective, demonstrating equivalent locoregional control (79.9% at 2 years) compared to 5 mm margins while significantly reducing acute grade 3 toxicity (53.8% vs 65%, p=0.032) 1
Without daily imaging: A 5 mm isometric PTV margin should be considered safe 2
Site-specific considerations for head and neck: Skull base locations demonstrate lower setup uncertainties and may use 1.5-2 mm margins, while neck and mucosal sites require 2-2.5 mm margins due to greater positioning errors and internal organ motion 3
CTV Definition for Sarcomas
For soft tissue sarcomas, the CTV construction follows established principles:
Gross tumor volume (GTV): Include the primary tumor and any involved regional lymph nodes as identified on planning CT, MRI, and PET imaging 4
CTV expansion from GTV: Add 1.0-2.0 cm margin to account for microscopic invasion, modified to include abnormalities on T2-weighted or FLAIR MRI sequences and constrained by anatomical barriers (ventricles, tentorium, falx) 5
For vulvar sarcoma as reference: The CTV extends from GTV/tumor bed plus adjacent skin, mucosa, and subcutaneous tissue, with the CTV trimmed by 3 mm from skin in absence of skin involvement 6
Final PTV Margin Application
After defining your CTV:
Add 3-5 mm for PTV to compensate for residual setup uncertainties and intrafraction motion 7
With ExacTrac or equivalent 6D positioning: Consider reducing to 3 mm for skull base locations and maintaining 3-5 mm for neck locations 3
Verify with daily CBCT: This enables safe margin reduction while maintaining tumor control 1, 8
Critical Technical Requirements
Image Guidance Mandates
Daily volumetric imaging (CBCT or equivalent) is essential before each fraction when using reduced margins 1, 8
Immobilization device is strongly recommended for reproducibility of daily setup 4
Radio-opaque markers should be placed on key anatomical landmarks at simulation to assist target volume definition 6
Dose Prescription Considerations
For definitive treatment of head and neck sarcoma:
High-risk sites (primary tumor and involved nodes): 66-70 Gy in 2.0-2.2 Gy fractions 9, 10
Definitive radiotherapy alone (unresectable cases): 66 Gy in 33 fractions over 6.5 weeks 10
Postoperative settings: 50 Gy to tumor bed, with boost of 10-18 Gy for positive margins depending on normal tissue tolerance 11
Common Pitfalls to Avoid
Do not use symmetric geometric expansions around vessels for nodal volumes in head and neck cases - instead, use anatomically-based contouring with specific muscle boundaries 6
Do not exceed 5 mm margins without daily image guidance, as this increases toxicity without improving outcomes 1
Do not reduce margins below 3 mm for neck and mucosal sites even with daily imaging, as these locations show significantly more positioning uncertainties than skull base sites 3
Ensure institutional experience with reduced-margin techniques before implementation, as technical capabilities and quality assurance processes must support high-precision delivery 7